RSS   Newsletter   Contact   Advertise with us

China-developed nasal spray vaccine for coronavirus approved for clinical trials

Christian Fernsby ▼ | September 10, 2020
The University of Hong Kong (HKU) announced that the clinical trials of a nasal spray vaccine for coronavirus jointly developed by the university's Department of Microbiology and mainland institutions have been approved.
University of Hong Kong
Nasal spray   University of Hong Kong
The State Key Laboratory of Emerging Infectious Diseases has been working on the vaccine with Xiamen University and Beijing Wantai Biological Pharmacy.

It is the first nasal spray COVID-19 vaccine approved by the China's National Medical Products Administration for clinical trial in humans.

The HKU said in a statement that its vaccine strategy has been selected as one of the five vaccine technologies by the Ministry of Science and Technology for further evaluation.